Fox Chase Cancer Center Welcomes Dr. David Loren

David Loren
Fox Chase Cancer Center is pleased to announce the hiring of David Loren, MD, FASGE, as professor of medicine and chief of the Section of Gastroenterology in the Department of Medicine.

PHILADELPHIA (June 6, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of David Loren, MD, FASGE, as professor of medicine and chief of the Section of Gastroenterology in the Department of Medicine.

Loren has been a practicing physician in Philadelphia for over 20 years and specializes in the prevention, diagnosis, and treatment of diseases of the pancreas and bile ducts, with a dedicated focus on advanced interventional endoscopy in pancreaticobiliary cancers.

Prior to joining Fox Chase, Loren spent over 20 years in the Division of Gastroenterology in the Department of Medicine at Thomas Jefferson University in Philadelphia. During his tenure at Jefferson Loren was appointed the Director of Endoscopy Services for Jefferson Health, Associate Director of the Pancreatobiliary Disease Center, and Director of the Therapeutic Endoscopy Fellowship.

Loren received both his undergraduate and his medical degrees from Washington University in St. Louis. He pursued internship and residency in internal medicine at Beth Israel Hospital in Boston and completed his senior residency at the University of Pennsylvania, where he also completed a categorical fellowship in gastroenterology and hepatology. He then completed additional training in advanced and therapeutic endoscopy at Jefferson.

He currently serves as president of the Foundation for Interventional and Therapeutic Endoscopy and is past-president and current treasurer of the Delaware Valley Society for Gastrointestinal Endoscopy. He is a member of the American Society for Gastrointestinal Endoscopy, American Gastroenterological Association, and the American College of Gastroenterology.

Loren is a distinguished clinician in therapeutic and advanced endoscopy, and while at Jefferson he led one of the largest programs for endoscopic treatments of biliary cancers in the United States. He has earned numerous honors recognizing his abilities as a researcher and educator, including the Dean’s Citation for Significant Contributions to the Advancement of Education and the Award for Excellence in Teaching and Bedside Education from Jefferson. He is also a multiple winner of the American College of Gastroenterology Presidential Research Poster Award. Loren has been named a Top Doctor by Philadelphia magazine annually from 2017 through 2023.

Loren is extensively published in peer-reviewed journals, has co-authored medical textbooks, and is a sought-after speaker who has delivered lectures nationally and internationally. Over his career he has trained almost 100 gastroenterology fellows and over 20 fellows dedicated to the field of advanced therapeutic endoscopy.

Loren began his tenure at Fox Chase on May 15.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427